SE8001748L - Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik - Google Patents

Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik

Info

Publication number
SE8001748L
SE8001748L SE8001748A SE8001748A SE8001748L SE 8001748 L SE8001748 L SE 8001748L SE 8001748 A SE8001748 A SE 8001748A SE 8001748 A SE8001748 A SE 8001748A SE 8001748 L SE8001748 L SE 8001748L
Authority
SE
Sweden
Prior art keywords
structural element
mammals including
including man
compositions
antibodies
Prior art date
Application number
SE8001748A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Inventor
Gunilla Kellenius
Arne Lundblad
Roland Mollby
Stefan Svensson
Jan Winberg
Original Assignee
Kaellenius Gunilla
Arne Lundblad
Roland Mollby
Stefan Svensson
Jan Winberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaellenius Gunilla, Arne Lundblad, Roland Mollby, Stefan Svensson, Jan Winberg filed Critical Kaellenius Gunilla
Priority to SE8001748A priority Critical patent/SE8001748L/
Priority to JP56500784A priority patent/JPH0322397B2/ja
Priority to FI824526A priority patent/FI824526A0/fi
Priority to EP81850035A priority patent/EP0035484B1/en
Priority to DE8181850035T priority patent/DE3165623D1/de
Priority to AT81850035T priority patent/ATE9062T1/de
Priority to AU67795/81A priority patent/AU546148B2/en
Priority to US06/317,894 priority patent/US4657849A/en
Priority to PCT/SE1981/000065 priority patent/WO1981002520A1/en
Publication of SE8001748L publication Critical patent/SE8001748L/
Priority to NO813738A priority patent/NO161644C/no
Priority to DK489581A priority patent/DK489581A/da
Priority to FI814230A priority patent/FI71432C/fi
Priority to US06/892,807 priority patent/US4762824A/en
Priority to DK075787A priority patent/DK75787A/da
Priority to NO880662A priority patent/NO880662D0/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232—Escherichia (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8001748A 1980-03-05 1980-03-05 Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik SE8001748L (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE8001748A SE8001748L (sv) 1980-03-05 1980-03-05 Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
US06/317,894 US4657849A (en) 1980-03-05 1981-03-05 Compositions and methods useful for uropathogenic bacterial identification or diagnosis and inhibition of adherence of uropathogenic bacteria to cells having a structural element similar to that of the active principle of the invention
PCT/SE1981/000065 WO1981002520A1 (en) 1980-03-05 1981-03-05 Compositions for therapeutic or diagnostic use in connection with bacterial infections,and their use
EP81850035A EP0035484B1 (en) 1980-03-05 1981-03-05 Composition for therapeutic or diagnostic use
DE8181850035T DE3165623D1 (en) 1980-03-05 1981-03-05 Composition for therapeutic or diagnostic use
AT81850035T ATE9062T1 (de) 1980-03-05 1981-03-05 Zusammensetzung fuer die therapeutische oder diagnostische verwendung.
AU67795/81A AU546148B2 (en) 1980-03-05 1981-03-05 Composition for therapeutic or diagnostic use and a process for therapeutic treatment
JP56500784A JPH0322397B2 (da) 1980-03-05 1981-03-05
FI824526A FI824526A0 (fi) 1980-03-05 1981-03-05 Anvaendning som aktiv bestaondsdel foer framstaellning av en farmaceutisk komposition av ett strukturelement, foeretraedesvis i terminalstaellning
NO813738A NO161644C (no) 1980-03-05 1981-11-04 Preparater for in vitro diagnostisk bruk.
DK489581A DK489581A (da) 1980-03-05 1981-11-04 Praeparat til terapeutisk eller diagnostisk anvendelse og fremgangsmaade til terapeutisk behandling
FI814230A FI71432C (fi) 1980-03-05 1981-12-31 Diagnostiska kompositioner och deras anvaendning i samband medbakterieinfektioner
US06/892,807 US4762824A (en) 1980-03-05 1986-08-01 Compositions and methods useful for uropathogenic bacterial identification or diagnosis and inhibition of adherence of uropathogenic bacteria to cells having a structural element similar to that of the active principle of the invention
DK075787A DK75787A (da) 1980-03-05 1987-02-13 Praeparat til terapeutisk eller diagnostisk anvendelse og fremgangsmaade til terapeutisk behandling
NO880662A NO880662D0 (no) 1980-03-05 1988-02-15 Fremgangsmaate for identifisering eller kvantifisering av bakterier som forekommer i naturlig biologisk materiale fra pattedyr.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8001748A SE8001748L (sv) 1980-03-05 1980-03-05 Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik

Publications (1)

Publication Number Publication Date
SE8001748L true SE8001748L (sv) 1981-09-06

Family

ID=20340427

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8001748A SE8001748L (sv) 1980-03-05 1980-03-05 Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik

Country Status (10)

Country Link
US (2) US4657849A (da)
EP (1) EP0035484B1 (da)
JP (1) JPH0322397B2 (da)
AT (1) ATE9062T1 (da)
AU (1) AU546148B2 (da)
DE (1) DE3165623D1 (da)
DK (2) DK489581A (da)
FI (1) FI71432C (da)
SE (1) SE8001748L (da)
WO (1) WO1981002520A1 (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57500609A (da) * 1980-05-09 1982-04-08
US4521592A (en) * 1981-10-23 1985-06-04 Svenska Sockerfabriks Ab Compounds for therapeutic or diagnostic use, a process and intermediates for their preparation
AU561066B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Antibacterial composition containing an oligosaccharide
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
DK131083A (da) * 1982-03-23 1983-09-24 Svenska Sockerfabriks Ab Fremgangsmaade til fremstilling af terapeutiske eller diagnostiske praeparater
SE8301609D0 (sv) * 1983-03-23 1983-03-23 Svenska Sockerfabriks Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling
SE8304006D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
SE8304007D0 (sv) * 1983-07-15 1983-07-15 Karlsson Karl Anders Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
DE3402739A1 (de) * 1984-01-27 1985-08-01 Boehringer Ingelheim Diagnostika GmbH, 8046 Garching Antikoerper gegen den glycanstrang des peptidoglycans, verfahren und reagenzien zu ihrer herstellung und methoden zu ihrer quantitativen bestimmung
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
SE8406626D0 (sv) * 1984-12-27 1984-12-27 Bio Carb Ab Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
IL76981A (en) * 1985-11-07 1989-02-28 Univ Ramot Bacterially produced hetero polysaccharide dispersants for inorganic minerals in aqueous medium and their preparation
US5324828A (en) * 1986-12-11 1994-06-28 Genzyme Corporation 1-amino-1-deoxyoligosaccharides and derivatives thereof
US4942224A (en) * 1987-01-12 1990-07-17 The Biomembrane Institute A-associated H-antigens, monoclonal antibodies specific thereto and methods for employing the same in blood typing
US4857639A (en) * 1987-01-12 1989-08-15 The Biomembrane Institute A-associated H-antigens, monoclonal antibodies specific thereto and methods for employing the same in blood typing
US5167925A (en) * 1988-06-08 1992-12-01 North Carolina State University Precipitation of multivalent antiligands with affinity surfactants
US5112770A (en) * 1988-06-08 1992-05-12 North Carolina State University Precipitation of multivalent antiligands with affinity surfactants
US5164298A (en) * 1988-06-24 1992-11-17 Hsc Research Development Corporation Verocytotoxin receptor assay
US5217715A (en) * 1988-08-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Carbohydrate receptor for bacteria and method for use thereof
US5089479A (en) * 1988-11-28 1992-02-18 Krivan Howard C Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide
DK455088D0 (da) * 1988-08-12 1988-08-12 Symbicom Ab Syntetiske receptoranaloger
WO1991008748A1 (en) * 1989-12-13 1991-06-27 Glycomed Incorporated Synthesis of rotavirus receptor saccharides
WO1991008747A1 (en) * 1989-12-13 1991-06-27 Glycomed Incorporated Synthetic receptor molecules recognizable by a rotavirus
US5466681A (en) * 1990-02-23 1995-11-14 Microcarb, Inc. Receptor conjugates for targeting penicillin antibiotics to bacteria
DK0553113T3 (da) * 1990-08-02 1999-08-09 Antex Biolog Inc Adhæsionsreceptorer for patogene eller opportunistiske mikroorganismer
SE9003222L (sv) * 1990-10-10 1992-04-11 Jens Sandros Preparat foer profylaktiskt,terapeutiskt och diagnostiskt bruk vid infektioner
FR2671100B1 (fr) * 1990-12-28 1993-03-05 Bio Merieux Procede d'analyse bacteriologique, et milieu de detection des bacteries genre salmonella.
EP0610356B1 (en) * 1991-10-18 2001-01-31 SYNSORB Biotech Inc. Treatment of bacterial dysentery
AU6663294A (en) * 1993-05-14 1994-12-12 Upjohn Company, The Cloned dna encoding a udp-galnac:polypeptide,n-acetylgalactos aminyltransferase
US5910570A (en) * 1995-11-13 1999-06-08 Pharmacia & Upjohn Company Cloned DNA encoding a UDP-GalNAc: polypeptide N-acetylgalactosaminy-ltransferase
US6096725A (en) * 1997-07-02 2000-08-01 Neose Technologies, Inc. Methods of using αGal oligosaccharides as immune system targeting agents
CA2326618A1 (en) * 1998-04-15 1999-10-21 Baxter International Inc. Inhibition of xenoreactive antibodies
JP3772204B2 (ja) * 2000-06-05 2006-05-10 独立行政法人産業技術総合研究所 糖鎖誘導体及びその製造方法
US7238677B2 (en) * 2003-03-28 2007-07-03 Kimberly-Clark Worldwide, Inc. Prevention of urogenital infections
US20050095219A1 (en) * 2003-10-29 2005-05-05 Shu-Ping Yang Compositions for promoting vaginal cell proliferation and maturation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1910715A1 (de) * 1968-03-04 1969-10-09 Stanley Drug Products Inc Antimikrobielle Faktoren und deren Verwendung
US4125492A (en) * 1974-05-31 1978-11-14 Pedro Cuatrecasas Affinity chromatography of vibrio cholerae enterotoxin-ganglioside polysaccharide and the biological effects of ganglioside-containing soluble polymers
GB1544908A (en) * 1975-07-08 1979-04-25 Chembiomed Ltd Artificial oligosaccharide antigenic determinants
FR2422681A1 (fr) * 1978-04-10 1979-11-09 Anvar Procede de preparation de derives d'osides, les nouveaux derives d'osides obtenus et leurs applications biologiques

Also Published As

Publication number Publication date
DK489581A (da) 1981-11-04
FI814230L (fi) 1981-12-31
AU6779581A (en) 1981-09-23
EP0035484A3 (en) 1981-09-16
JPH0322397B2 (da) 1991-03-26
WO1981002520A1 (en) 1981-09-17
US4762824A (en) 1988-08-09
JPS57500194A (da) 1982-02-04
DK75787D0 (da) 1987-02-13
US4657849A (en) 1987-04-14
FI71432B (fi) 1986-09-09
DE3165623D1 (en) 1984-09-27
EP0035484B1 (en) 1984-08-22
DK75787A (da) 1987-02-13
EP0035484A2 (en) 1981-09-09
ATE9062T1 (de) 1984-09-15
FI71432C (fi) 1986-12-19
AU546148B2 (en) 1985-08-15

Similar Documents

Publication Publication Date Title
SE8001748L (sv) Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
DK609985A (da) Adhesin-antigener, antistoffer mod disse og dna-fragmenter, som indkoder antigenerne
DE69333802D1 (de) Äusseres membranprotein von haemophilus
JPH01157387A (ja) ヘモフィラス・インフルエンザワクチン
ATE67504T1 (de) Insulin-receptor, seine reinigung, seine herstellung in rekombinanten zellen, dna hierfuer, antikoerper gegen den insulin-receptor und deren herstellung, sowie pharmazeutische zusammensetzungen, die diese antikoerper enthalten.
HUP9900920A2 (hu) Eljárás emlőssejt-tenyészetekben termelt proteinek szializációjának szabályozására
ATE352314T1 (de) Aktive immunisierung gegen ein siderophores rezeptorprotein
ATE245699T1 (de) Rekombinant pgp3, verfahren zu dessen herstellung,und dessen verwendung in der diagnose und therapie
ES2130121T3 (es) Antigeno intra-acrosomico de esperma humano para uso en una vacuna anticonceptiva.
ATE25246T1 (de) Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
ATE38988T1 (de) Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
DK311485D0 (da) Fremgangsmaade til fremstilling af ikke-toksisk lt-b-underenhed i e. coli-enterotoksin
WO1998006850A1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
WO1988008032A1 (fr) Recepteur du petit groupe de recepteurs de rhinovirus
ATE27157T1 (de) Cycloalkylderivate von benzisoselenazolonen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
Karakawa et al. Characterization of the surface antigens of Staphylococcus aureus, strain K-93M
DE4400990A1 (de) Antikörper für den Nachweis von Salmonellen
Castermans et al. Transplantation immunity: separation of antigenic components from isolated nuclei
ATE73807T1 (de) Neue benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte.
EP1238280A2 (de) Mittel und verfahren zur diagnose von lyme borreliose sowie borreliose-impfstoff
ATE207119T1 (de) Die herstellung von menschlichen, monoklonalen antikörpern, die gegen das oberflächenantigen von hepatitis b aktiv sind
SE8206128L (sv) Farmaceutisk komposition for behandling av njurstenar framkallade genom infektion
ATE7700T1 (de) 2-hydroxy-1,2,4-butantricarbonsaeure-oligoribosi - derivate, verfahren zu ihrer herstellung und ihre verwendung als prophylaktische mittel gegen zahnkaries.
RU93020806A (ru) Способ получения антибруцеллезной сыворотки
EP1890150A1 (de) Bestimmung agonistischer, mit der humoralen Nierenabstossung assoziierten Autoantikörper

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8001748-6

Format of ref document f/p: F